BioInformant specializes in global strategic reports for the stem cell industry. We are the only company that has specifically served the stem cell sector since it emerged, and our singular focus allows us to produce data that enables you to better understand your markets, competitors, and customers.

BioInformant has been featured on prominent news outlets that include Nature Biotechnology, CBS News, the Wall Street Journal, Yahoo Finance, Medical Ethics, MarketWatch, Center for BioNetworking, and more.

A U.S. based company, our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and we are trained in applying these advanced data analysis techniques to the field of stem cell market research.

Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, Thermo Fisher Scientific, and many more, BioInformant is your trusted source of stem cell industry data.

What Can We Do For You?

Whether you already supply stem cell products or you're preparing to introduce them to the market, you know the importance of making informed, strategic decisions. You have to make effective product development decisions, sell effectively to scientists, generate improved revenues, and take market share from your competition.

With access to industry-leading stem cell market intelligence, you can reduce your risk and take advantage of new opportunities before your competitors are aware of them.
Because cord blood contains valuable hematopoietic stem cells, we also offer a "Global Cord Blood Industry Database, 2014" containing nearly 7,000 industry contacts. Use this database to understand the characteristics of this market and quantify market participants.

Why Should You Do Business with Us?

1) We are the only research firm in the marketplace that specializes exclusively in stem cell industry data. Because we have been tracking the sector for nearly a decade, we have the most comprehensive research database in the marketplace.

2) Our leadership team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and we're trained in applying these advanced research techniques to the field of market research. Analyzing stem cell industry data is a breeze, compared to managing billions of DNA base pairs.

3) We are the only provider of stem cell market intelligence that offers a 60-Day Money Back Guarantee on all products, to ensure your complete satisfaction and allow you to act risk-free.

4) We serve nearly all of the key players within the stem cell marketplace, including Pfizer, Merck, Thermo Fisher Scientific, BD Biosciences, GE Healthcare, Sanofi-Aventis, and more. With this experience, you can trust the quality of our data.

5) As a U.S. based provider, all BioInformant reports come with complimentary support from our Research & Analysis team, which has been tracking the market for nearly a decade. We follow-up to help you implement and utilize your stem cell industry data. No other provider offers this unusual level of support and expertise!


While BioInformant has been featured on prominent news outlets that include Nature Biotechnology, the Wall Street Journal, CBS News, Yahoo Finance, Medical Ethics, MarketWatch, the Center for BioNetworking, and many more, we think that our clients say it best:

"A special effort was made to render this excellent report accessible to us. The discussions that followed were very helpful, and will contribute to the realization of our objective which is to establish a public cord blood bank in sub-Saharan Africa."

Michael S. Pepper, MBChB, PhD, MD
Director, Institute for Cellular and Molecular Medicine
Professor, Dept. Immunology, Faculty of Health Sciences

"I was truly impressed by BioInformant. You can trust BioInformant to do things right and generate greater awareness of your technology. They are the go-to resource for stem cell researchers and companies looking for trustworthy stem cell business information and marketing support."

Dr. William Frey II
Founder and Co-Director of the Alzheimer's Research Center

"I am now truly enlightened. You are awesome! I must say it has been an absolute pleasure working with you folks. You will always get a great customer recommendation from me."

John Jaskowiak
Vice President, Angiocrine Bioscience

"The BioInformant team was great to work with. The cord blood report we claimed was comprehensive and informative and the team was extremely responsive to all of our questions. I would highly recommend them to anyone interested in learning more about the cord blood and cord tissue markets."

Kevin Cox
Private Equity Analyst, Audax Group

"BioInformant puts enormous time and effort into their products, which are accurate and precise. Their cord blood industry knowledge is outstanding, so cord blood banks and investors actively seek out their expertise. The BioInformant Team is very efficient and it is always a pleasure to do business with them."

Sonja Seeburger
Business Development Manager,

"BioInformant works diligently to spread awareness about cord blood and stem cell advances. BioInformant has BI partnerships with the top cord blood banks worldwide, acts as a media expert on cord blood industry topics, and has research that has also been cited by the WSJ, National Marrow Donor Program, Nature Biotechnology, Medical Ethics, and more. I highly recommend BioInformant to any investors seeking market intelligence about stem cells, particularly cord blood stem cells."

Jeremiah Boucher
Commercial & Private Investor

(Phone) 703-859-7617 (Fax) 614-352-2369

Copyright © 2014 BioInformant Worldwide, L.L.C. All rights reserved.

Home | Products | Guarantee | Testimonials | Company | Contact Us

60-Day Money Back Guarantee:
All BioInformant products come guaranteed. If the strategies and tools aren't helpful to you - we'll cheerfully refund your money, and you can keep the product.

Follow Our Stem Cell Industry Alerts: